comparemela.com

Ocelot Bio, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics to treat complications of end-stage liver disease (ESLD), today announced that the U.S. Food and Drug Administration (FDA) has granted...

Related Keywords

United States ,Lise Kjems ,Gastroenterol Hepatol ,Product Service ,Drug Administration ,Ocelot Bio Inc ,Drug Designation ,Orphan Drug Designation ,Ocelot Bio ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.